Join us for a webinar on Thursday, September 5 at 11 am PDT. https://hubs.ly/Q02NwF7D0
Ambry Genetics
Biotechnology Research
Aliso Viejo, CA 70,356 followers
Finding Answers Through Quality Genetic Testing
About us
Ambry Genetics is a company built by scientists, genetic counselors and physicians, dedicated to leading the clinical genomic diagnostic industry. Ambry boasts the largest genetic sequencing lab in the world; is CAP-accredited, CLIA-licensed and, as part of the Konica Minolta family, has access to the most complete suite of diagnostic technology in the world. Ambry Genetics' scope of clients includes some of the world's most respected academic institutions, pharmaceutical companies and leading treatment hospitals. Our experience, technology and dedication to science make us a trusted source for all clinical genetic testing, and an ideal partner for developing precision medicine solutions. Patients are at the core of everything we do, which is why Ambry partners with several non-profit organizations so that we can help both patients and clinicians alike find answers. Hiring Fraud Alert: Ambry/REALM IDx has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry/REALM IDx recruiter(s). If you’ve experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://realmidx.com/careers/recruitment-fraud-alert/ to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://realmidx.com/careers/.
- Website
-
https://www.ambrygen.com
External link for Ambry Genetics
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Aliso Viejo, CA
- Type
- Privately Held
- Founded
- 1999
- Specialties
- Molecular Diagnostic Testing, Clinical Diagnostic Exome, Breast Cancer Genetics, Hereditary Cancer, Cardio Genetics, Neuro Genetics, General Genetics, Family History Questionnaire, Pedigree Drawing Tool, and Risk Assessment Tool
Locations
-
Primary
1 Enterprise
Aliso Viejo, CA 92656, US
-
7 Argonaut
Aliso Viejo, CA 92656, US
Employees at Ambry Genetics
Updates
-
Are you ready to equip your healthcare team to give patients options that could be lifesaving? The Ambry CARE Program®️ leverages digital health solutions to enable health systems to stratify patients by cancer risks, driving care that is proactive and patient-centric. This empowers clinicians to make timely, evidenced-based medical decisions while benefiting from improved practice productivity. Learn more: https://hubs.ly/Q02N0Yq80 #proactive #patientcentric #CARE
-
-
ICYMI: We just launched a new exome product! ExomeReveal™️ adds RNA analysis to exome testing for a 2-3% increase in diagnostic yield. Exome testing has officially entered its RNA era. Learn more: https://hubs.ly/Q02MYmZS0 #exome #VUS #raredisease #settingthestandard #experiencematters
-
Space Gnome is reaching new heights in genomic discovery! His journey to space began as a whimsical idea that transformed into a groundbreaking mission. With the help of a dedicated team at Ambry, including a former NASA scientist, Space Gnome was launched to over 109,000 feet, becoming the first gnome to carry a fully sequenced genome into space. Captured in stunning real footage, his adventure, viral on YouTube (https://hubs.ly/Q02MTBY_0), showcases a blend of scientific achievement and gnome-sized heroics. Space Gnome embodies the boundless potential of combining curiosity with cutting-edge science, inspiring future generations of explorers. Ambry Genetics has always been a pioneer in the field, and we won't stop until all human disease is understood, proving that no frontier is too far in the pursuit of knowledge! #Ambry25 #AmbryGnomes
-
-
Happy Labor Day! Today, we celebrate the hard work, dedication, and achievements of workers across the nation. Whether you're taking a well-deserved break or scheduled to cover a shift for the holiday, we honor your contributions that keep our communities thriving. At Ambry, we believe in the power of teamwork and the importance of every role. The relentless effort and passion of our employees is the reason we can celebrate 25 years of service. Enjoy this day dedicated to you! #LaborDay #Ambry25 #OneAmbry
-
-
We're looking forward to the Innovations in Genetic Testing Lunch Symposium at NSGC! Join Ambry presenters Carrie Horton, Senior Medical Liaison and Clinical Researcher, and Jennifer Herrera-Mullar, Principal Clinical Scientist, and guest speaker, Dr. Tuya Pal, a board certified clinical geneticist and researcher from the Vanderbilt-Ingram Cancer Center, for an in-depth look at how Ambry Genetics approaches the design of genetic testing menus and panels, emphasizing gene-disease validity, clinical utility, and the evolving landscape of clinical testing. #NSGC2024 #Ambry25
-
-
Shout out to all the genetic counselors! Your commitment to patients is key to promoting healthcare equity. Thank you for partnering with us to reach underserved communities and provide genetic testing to all who need it. You are the boots on the ground who can impact patient lives. #Ambry25 #genechat #genetictesting #geneticcounselor #experiencematters #NSGC2024
-
-
Ambry is proud to have been the first lab to offer paired DNA and RNA testing for hereditary cancer. Approximately 1 in 50 hereditary cancer patients would be missed without +RNAinsight®. Learn more: https://hubs.ly/Q02MWt3b0 #Ambry25 #experiencematters #settingthestandard
-
-
Find out the difference RNA can make as Ambry's own Dr. Rachid Karam joins the "DNA Today" podcast to share our experience with +RNAinsight® for hereditary cancer testing and ExomeReveal™ for rare disease.
We are renaming our show “RNA Day” 🤣 Did you know that RNA analysis can boost diagnostic yield, reduce VUSes, and help close health disparity gaps? Our latest DNA Today episode features Dr. Rachid Karam, VP of Research and Development at Ambry Genetics, who answers these questions and more! We dive into Ambry's pioneering RNA testing history, its impact on increasing diagnostic yield, reducing Variants of Uncertain Significance in hereditary cancer testing, and closing health disparity gaps. Plus, we introduce ExomeReveal, Ambry's new exome testing product that includes RNA analysis, extending expertise to rare diseases. 🎧 Listen now, search “DNA Today” in your podcast player or here: https://lnkd.in/ejcn-cuX #Genetics #RNATesting #ExomeTesting #HealthInnovation #VUS
-
After SCOTUS ruled they couldn't patent our gene FREEDOM, Ambry continued on their quest for innovation. Dubbed Sir Genefree Braveheart by one of our Genomic Science Liaisons, this gnome made his debut in 2014. That year, Ambry started structural assessments. We strive to incorporate technology to provide answers to more patients. What advancement do you think has made the biggest difference in the last 25 years and what are your predictions for the future? #Ambry25 #AmbryGnomes
-